Acton, MA, United States of America

Sheila Seepersaud

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Sheila Seepersaud: Innovator in Hepatitis C Research**

Introduction

Sheila Seepersaud, an esteemed inventor based in Acton, MA, has made significant contributions to medical research, particularly in the field of infectious diseases. With her innovative methods for amplifying hepatitis C virus nucleic acids, she has paved the way for advancements in diagnosing and understanding hepatitis C.

Latest Patents

Sheila holds a patent for her groundbreaking work titled "Methods for amplifying hepatitis C virus nucleic acids." This invention outlines a two-stage PCR method that effectively amplifies segments of a DNA template that complement the genome of hepatitis C virus RNA from infected samples. The detailed steps involve using a set of precise outer and inner primers, with specific nucleotide sequences for optimal amplification. Her work plays a crucial role in improving diagnostic techniques for hepatitis C, thereby impacting patient care positively.

Career Highlights

Sheila Seepersaud is associated with Vertex Pharmaceuticals, Inc., a leading enterprise in biotechnology. Her role at this innovative company has allowed her to engage in cutting-edge research and develop vital methodologies that combat viral infections. With her dedication and expertise, Sheila has become a respected figure in her field.

Collaborations

In her journey at Vertex Pharmaceuticals, Sheila has collaborated with several notable researchers, including Ann Dak-Yee Kwong and James Daniel Frantz. Together, they have contributed to a collective body of research aimed at advancing medical science and developing new therapeutic techniques.

Conclusion

Sheila Seepersaud stands out as a prominent inventor whose work in amplifying hepatitis C virus nucleic acids demonstrates the vital intersection of innovation and medical research. Her contributions not only enhance scientific understanding but also aim to improve the lives of those affected by hepatitis C. As she continues her work in this critical field, she embodies the spirit of innovation and dedication that drives progress in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…